SPAC公司Bowen Acquisition(BOWN.US)与深圳仟枝生物科技合并

智通财经01-19

智通财经APP获悉，特殊目的收购公司(SPAC)Bowen Acquisition(BOWN.US)宣布，已与深圳仟枝生物科技有限公司(Shenzhen Qianzhi Biotechnology Co., Ltd)达成最终合并协议。该交易预计将于2024年第二季度或第三季度完成。据悉，深圳仟枝生物科技有限公司是一家专门从事臭氧健康和保健产品的中国生物技术公司。根据协议，深圳仟枝生物科技有限公司将...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2404957736?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-01-19 20:19","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2404957736","market":"sh","top_or_hot":-1,"title":"SPAC公司Bowen Acquisition(BOWN.US)与深圳仟枝生物科技合并","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，特殊目的收购公司(SPAC)Bowen Acquisition(BOWN.US)宣布，已与深圳仟枝生物科技有限公司(Shenzhen Qianzhi Biotechnology Co., Ltd)达成最终合并协议。该交易预计将于2024年第二季度或第三季度完成。据悉，深圳仟枝生物科技有限公司是一家专门从事臭氧健康和保健产品的中国生物技术公司。根据协议，深圳仟枝生物科技有限公司将...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1058422.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SPAC公司Bowen Acquisition(BOWN.US)与深圳仟枝生物科技合并</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSPAC公司Bowen Acquisition(BOWN.US)与深圳仟枝生物科技合并\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-01-19 20:19 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1058422.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，特殊目的收购公司(SPAC)Bowen Acquisition(BOWN.US)宣布，已与深圳仟枝生物科技有限公司(Shenzhen Qianzhi Biotechnology Co., Ltd)达成最终合并协议。该交易预计将于2024年第二季度或第三季度完成。据悉，深圳仟枝生物科技有限公司是一家专门从事臭氧健康和保健产品的中国生物技术公司。根据协议，深圳仟枝生物科技有限公司将...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1058422.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"WARR","symbol_name":"Warrior Technologies Acquisition Company","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1058422.html","article_id":"2404957736","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2404957736","pubTimestamp":1705666771,"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP获悉，特殊目的收购公司Bowen Acquisition宣布，已与深圳仟枝生物科技有限公司达成最终合并协议。根据协议，深圳仟枝生物科技有限公司将成为Bowen Acquisition的全资子公司。前者的股东将获得总计725万股Bowen Acquisition普通股，并可能在达到一定的盈利目标后获得额外的140万股Bowen Acquisition普通股。深圳仟枝生物科技有限公司在一份声明中表示，合并后的公司将继续由其执行管理团队领导。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"WARR":"Warrior Technologies Acquisition Company","OTECU":"Oceantech Acquisitions I Corp.","NVACU":"NorthView Acquisition Corp","MCAAU":"Mountain & I Acquisition Co Corp","WARR.U":"Warrior Technologies Acquisition Company","OTEC":"Oceantech Acquisitions I Corp.","SVIIU":"Spring Valley Acquisition Corp. II","CNDA":"Concord Acquisition Corp II","QDROU":"Quadro Acquisition One Corp Unit 1 CL A & 1/3 RED WT EXP","LWACU":"Locust Walk Acquisition Corp.","SHAP.U":"Spree Acquisition Corp. I Ltd.","SVII":"Spring Valley Acquisition Corp II","VCXB":"10X Capital Venture Acquisition Corp. III","TMTC":"TMT ACQUISITION CORP","MCADR":"Mountain Crest Acquisition Corp. II Rights","OSI.U":"Osiris Acquisition Corp.","AAQC.U":"Accelerate Acquisition Corp.","BOWN":"Bowen Acquisition Corp","NNAGU":"99 Acquisition Group","AAQC":"Accelerate Acquisition Corp","PUCK":"Goal Acquisitions Corp.","BOWNU":"Bowen Acquisition Corp.","ROSS.U":"Ross Acquisition Corp II","PUCKU":"Goal Acquisitions Corp.","QOMOU":"Qomolangma Acquisition Corp","TCOA":"Trajectory Alpha Acquisition Corp.","VAQC":"Vector Acquisition Corporation II","MBAC":"M3-Brigade Acquisition II Corp","TSIAU":"TS Innovation Acquisitions Corp.","TLGYU":"TLGY Acquisition Corp","LIVBU":"LIV Capital Acquisition Corp II","MSSAU":"Metal Sky Star Acquisition Corp","LIVB":"LIV Capital Acquisition Corp II","OCAXU":"OCA Acquisition Corp.","IVCA":"Investcorp India Acquisition Corp","SEDA.U":"SDCL EDGE Acquisition Corp.","IPXX":"Inflection Point Acquisition Corp II","SSPKU":"Silver Spike Acquisition Corp.","WNNR.U":"Andretti Acquisition Corp.","LGV":"Longview Acquisition Corp II","OHAAU":"OPY Acquisition Corp I","SCRMU":"Screaming Eagle Acquisition Corp","OHAA":"OPY Acquisition Corp I","RACY":"Relativity Acquisition Corp","HSPO":"Horizon Space Acquisition I Corp","PACI.U":"PROOF Acquisition Corp I","RACYU":"Relativity Acquisition Corp","MNTN.U":"Everest Consolidator Acquisition Corp","DIST":"DISTOKEN ACQUISITION CORP","SAMAU":"Schultze Special Purpose Acquisition Corp. II","ATMVU":"ALPHAVEST ACQUISITION CORP UNITS 1 ORD SHS & 1 RT 1/10 SHS","SLAC":"Social Leverage Acquisition Corp I","LOCC.U":"Live Oak Crestview Climate Acquisition Corp.","KVAC":"KEEN VISION ACQUISITION CORPORATION","TGVC":"TG Venture Acquisition Corp.","ATMV":"ALPHAVEST ACQUISITION CORP","OXUSU":"Oxus Acquisition Corp.","TMTCU":"TMT Acquisition Corp.","OAKU":"Oak Woods Acquisition Corp","PFTA":"Portage Fintech Acquisition Corporation","OSTRU":"Oyster Enterprises Acquisition Corp.","MTRY":"Monterey Bio Acquisition Corp","OAKUU":"Oak Woods Acquisition Corp.","PHYT":"Pyrophyte Acquisition Corp","SHUAU":"SHUAA Partners Acquisition Corp I","NPAB":"New Providence Acquisition Corp II","NPABU":"New Providence Acquisition Corp II","WEL.U":"Integrated Wellness Acquisition Corp.","FORLU":"Four Leaf Acquisition Corp.","ONYXU":"Onyx Acquisition Co I","ACRO":"Acropolis Infrastructure Acquisition Corp.","MOTNU":"Motion Acquisition Corp.","NFNT":"Infinite Acquisition Corp.","NFNT.U":"Infinite Acquisition Corp.","OPA.U":"Magnum Opus Acquisition Limited","PHYT.U":"Pyrophyte Acquisition Corp.","TRCA.U":"Twin Ridge Capital Acquisition Corp.","NRACU":"NORTHERN REVIVAL ACQUISITION CORPORATION (1 CL A & 1/2 RED WT)","RMGBU":"ReNew Energy Global plc","NFYS.U":"ENPHYS ACQUISITION CORP.","RCFA.U":"RCF Acquisition Corp.","RRAC.U":"Rigel Resource Acquisition Corp.","NVAC":"Northview Acquisition Corp"},"translate_title":"SPAC Bowen Acquisition (BOWN.US) merged with Shenzhen Qianzhi Biotechnology","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AAQC":1,"AAQC.U":1,"ACRO":1,"ATMV":1,"ATMVU":1,"BOWN":1,"BOWNU":1,"CETU":1,"CNDA":1,"DIST":1,"FORLU":1,"HSPO":1,"IPXX":1,"IVCA":1,"KVAC":1,"LGV":1,"LIVB":1,"LIVBU":1,"LOCC.U":1,"LWACU":1,"MBAC":1,"MCAAU":1,"MCADR":1,"MNTN.U":1,"MOTNU":1,"MSSAU":1,"MTRY":1,"MTRYU":1,"NFNT":1,"NFNT.U":1,"NFYS":1,"NFYS.U":1,"NNAGU":1,"NPAB":1,"NPABU":1,"NRACU":1,"NVAC":1,"NVACU":1,"OAKU":1,"OAKUU":1,"OCAXU":1,"OHAA":1,"OHAAU":1,"ONYXU":1,"OPA.U":1,"OSI.U":1,"OSTRU":1,"OTEC":1,"OTECU":1,"OXUS":1,"OXUSU":1,"PACI.U":1,"PEGR":1,"PEPLU":1,"PFTA":1,"PHYT":1,"PHYT.U":1,"PLTNU":1,"PORT.U":1,"PUCK":1,"PUCKU":1,"QDROU":1,"QOMOU":1,"RACY":1,"RACYU":1,"RCFA.U":1,"RMGBU":1,"ROSS.U":1,"RRAC.U":1,"RWODU":1,"SAMAU":1,"SCRMU":1,"SEDA.U":1,"SHAP.U":1,"SHUAU":1,"SLAC":1,"SSPKU":1,"SUAC.U":1,"SVII":1,"SVIIU":1,"SZZL":1,"TCOA":1,"TENK":1,"TENKU":1,"TGVC":1,"TLGYU":1,"TMTC":1,"TMTCU":1,"TRCA.U":1,"TRTL.U":1,"TSIAU":1,"VAQC":1,"VCXB":1,"VCXB.U":1,"WARR":1,"WARR.U":1,"WEL.U":1,"WNNR.U":1,"XFIN":1,"XPDB":1,"XPDBU":1,"ZLSWU":1},"content_text":"智通财经APP获悉，特殊目的收购公司(SPAC)Bowen Acquisition(BOWN.US)宣布，已与深圳仟枝生物科技有限公司(Shenzhen Qianzhi Biotechnology Co., Ltd)达成最终合并协议。该交易预计将于2024年第二季度或第三季度完成。据悉，深圳仟枝生物科技有限公司是一家专门从事臭氧健康和保健产品的中国生物技术公司。根据协议，深圳仟枝生物科技有限公司将成为Bowen Acquisition的全资子公司。前者的股东将获得总计725万股Bowen Acquisition普通股，并可能在达到一定的盈利目标后获得额外的140万股Bowen Acquisition普通股。深圳仟枝生物科技有限公司在一份声明中表示，合并后的公司将继续由其执行管理团队领导。该公司还补充称，无法保证合并后的公司将继续在纳斯达克上市。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2404957736"}